BioSpace News Archive

Conformal Medical, Inc., developer of the Conformal Left Atrial Appendage Seal for LAA occlusion, reports the first human use of its proprietary technology for the prevention of stroke in patients with atrial fibrillation (AFib).

Foundation Medicine and Flatiron Health today announced the publication of study results in the Journal of the American Medical Association validating that real-world clinico-genomic data obtained during the course of routine patient care can yield scientifically and clinically meaningful insights.

Worldwide Clinical Trials, Inc., (Worldwide) further retained its position as an award-winning, full-service, midsize, global CRO with achievement of five 2019 CRO Leadership Awards, presented by Life Science Leader and Industry Standard Research (ISR).

The birth of the first healthy baby through the pioneering Maternal Spindle Transfer method – implemented for the first time by the Institute of Life and Embryotools – is a global first, offering the potential to preserve the mother’s genetic material.

Recognizing the potential of new technology for enhanced contamination control in cleanrooms where pharmaceuticals are made, RevDesinfectie Robots recently evaluated Xenex Disinfection Systems’ pulsed xenon ultraviolet (UV) light disinfection robots in live production cleanrooms.

Scientists have discovered certain molecules in the saliva that not only differentiate children with autism spectrum disorder (ASD), but appear to correlate with specific autism traits.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the launch of five new global grants programs to continue to support investigator-sponsored research in chronic hepatitis C virus (HCV) and hepatitis B virus (HBV), HCV and HIV co-infection, nonalcoholic steatohepatitis (NASH) and primary sclerosing cholangitis (PSC)

Robotic VISION Technologies, Inc. (RVT), announces today its exclusive license to 5 newly granted patents from the U.S. Patent & Trademark Office

Today, Citizens Against Government Waste (CAGW) released an analysis of misguided provisions in Gov. Tim Walz’s (D-Minn.) budget that would impose new taxes on pharmaceutical drugs in the name of halting the opioid crisis.

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Care.com, Inc. of the June 3, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.